The Ottawa Medical Artificial Intelligence Research Institute (OMARI) invites organizations with AI-based medical devices either in development or on the market to participate in a research study investigating and documenting regulatory considerations for AI in healthcare. The study aims to enable AI innovations and explore how organizations navigate evolving regulatory requirements, uncertainty, and practical challenges in the medical device licensing process in Canada.
Participation involves a one-time, 45-minute semi-structured interview via Microsoft Teams.
Insights will contribute to developing a regulatory playbook and practical recommendations for organizations. This will be shared with the community across Canada.
Please contact Dr. Khaled El Emam at kelemam@ehealthinformation.ca to express your interest or learn more.
The mission of the Ottawa Medical Artificial Intelligence Research Institute (OMARI) is to enable education and training, and to empower research, innovation and collaboration, in the rapidly evolving and transformative field of medical AI, to strengthen our health systems and improve patient care in Canada and beyond. OMARI is led by its Director, Dr. Khaled El Emam, Canada Research Chair (Tier 1) in Medical AI, Professor at the School of Epidemiology and Public Health at the University of Ottawa, and Senior Scientist at the CHEO Research Institute.